Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Agilent (A) PT Raised to $147 at BofA Securities
August 22, 2024 6:21 AM EDTBofA Securities analyst Derik de Bruin raised the price target on Agilent (NYSE: A) to $147.00 (from $140.00) while maintaining a Neutral rating.
The analyst comments "We update our forecasts, driving our PO to $147 (from $140), based on 20x CY25E Adj EBITDA vs 19x previously,... More
Agilent (A) PT Raised to $135 at Evercore ISI
August 22, 2024 5:17 AM EDTEvercore ISI analyst Vijay Kumar raised the price target on Agilent (NYSE: A) to $135.00 (from $130.00) while maintaining a In Line rating.
The analyst comments "A reported total revs of $1.578M (org decline of -4.5%), which came in ~130 bps above ST. The slightly better rev performance was driven by pharma (declined -8%) coming in slightly better, China (declined - 11%) a tad better and NASD inline with expecs (revs declined QoQ as expected). Relative to EVRe, a better biopharma, Dx & Environmental performance was partly offset by Food & Chemical end mkts coming in below.... More
Agilent (A) PT Raised to $165 at Citi
August 22, 2024 4:57 AM EDTCiti analyst Patrick Donnelly raised the price target on Agilent (NYSE: A) to $165.00 (from $150.00) while maintaining a Buy rating.
The analyst comments "Agilent reported a F3Q24 organic decline of (4.4%) ahead of guidance of (6.9%)-(4.5%) with adj. EPS of $1.32 above guidance of $1.25-1.28... More
